226 related articles for article (PubMed ID: 35957642)
1. A multi-organ-on-chip to recapitulate the infiltration and the cytotoxic activity of circulating NK cells in 3D matrix-based tumor model.
Marzagalli M; Pelizzoni G; Fedi A; Vitale C; Fontana F; Bruno S; Poggi A; Dondero A; Aiello M; Castriconi R; Bottino C; Scaglione S
Front Bioeng Biotechnol; 2022; 10():945149. PubMed ID: 35957642
[TBL] [Abstract][Full Text] [Related]
2. Fluid-Dynamic Culture of Tumour and Immune Cells for More Predictive Infiltration Studies and Immunotherapy Drug Screening.
Palamà MEF; Aiello M; Scaglione S
Methods Mol Biol; 2024; 2782():147-157. PubMed ID: 38622399
[TBL] [Abstract][Full Text] [Related]
3. A Human Ovarian Tumor & Liver Organ-on-Chip for Simultaneous and More Predictive Toxo-Efficacy Assays.
Fedi A; Vitale C; Fato M; Scaglione S
Bioengineering (Basel); 2023 Feb; 10(2):. PubMed ID: 36829764
[TBL] [Abstract][Full Text] [Related]
4. Suppression of the antitumoral activity of natural killer cells under indirect coculture with cancer-associated fibroblasts in a pancreatic TIME-on-chip model.
Kim HA; Kim H; Nam MK; Park JK; Lee MY; Chung S; Lee KM; Kuh HJ
Cancer Cell Int; 2023 Sep; 23(1):219. PubMed ID: 37759302
[TBL] [Abstract][Full Text] [Related]
5. Engineered Three-Dimensional Tumor Models to Study Natural Killer Cell Suppression.
Temples MN; Adjei IM; Nimocks PM; Djeu J; Sharma B
ACS Biomater Sci Eng; 2020 Jul; 6(7):4179-4199. PubMed ID: 33463353
[TBL] [Abstract][Full Text] [Related]
6. A three-dimensional immune-oncology model for studying in vitro primary human NK cell cytotoxic activity.
Thongsin N; Wattanapanitch M
PLoS One; 2022; 17(3):e0264366. PubMed ID: 35312698
[TBL] [Abstract][Full Text] [Related]
7. Identification of neuroblastoma cell lines with uncommon TAZ
Canzonetta C; Pelosi A; Di Matteo S; Veneziani I; Tumino N; Vacca P; Munari E; Pezzullo M; Theuer C; De Vito R; Pistoia V; Tomao L; Locatelli F; Moretta L; Caruana I; Azzarone B
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452207
[TBL] [Abstract][Full Text] [Related]
8. Cholangiocarcinoma-on-a-chip: A human 3D platform for personalised medicine.
Polidoro MA; Ferrari E; Soldani C; Franceschini B; Saladino G; Rosina A; Mainardi A; D'Autilia F; Pugliese N; Costa G; Donadon M; Torzilli G; Marzorati S; Rasponi M; Lleo A
JHEP Rep; 2024 Jan; 6(1):100910. PubMed ID: 38074504
[TBL] [Abstract][Full Text] [Related]
9. Advances in Modeling the Immune Microenvironment of Colorectal Cancer.
Yoon PS; Del Piccolo N; Shirure VS; Peng Y; Kirane A; Canter RJ; Fields RC; George SC; Gholami S
Front Immunol; 2020; 11():614300. PubMed ID: 33643296
[TBL] [Abstract][Full Text] [Related]
10. Organ on Chip Technology to Model Cancer Growth and Metastasis.
Imparato G; Urciuolo F; Netti PA
Bioengineering (Basel); 2022 Jan; 9(1):. PubMed ID: 35049737
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment.
Zhang J; Tavakoli H; Ma L; Li X; Han L; Li X
Adv Drug Deliv Rev; 2022 Aug; 187():114365. PubMed ID: 35667465
[TBL] [Abstract][Full Text] [Related]
12. 3D Immunocompetent Organ-on-a-Chip Models.
Maharjan S; Cecen B; Zhang YS
Small Methods; 2020 Sep; 4(9):. PubMed ID: 33072861
[TBL] [Abstract][Full Text] [Related]
13. Oncoimmunology Meets Organs-on-Chip.
Mattei F; Andreone S; Mencattini A; De Ninno A; Businaro L; Martinelli E; Schiavoni G
Front Mol Biosci; 2021; 8():627454. PubMed ID: 33842539
[TBL] [Abstract][Full Text] [Related]
14. Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment.
Courau T; Bonnereau J; Chicoteau J; Bottois H; Remark R; Assante Miranda L; Toubert A; Blery M; Aparicio T; Allez M; Le Bourhis L
J Immunother Cancer; 2019 Mar; 7(1):74. PubMed ID: 30871626
[TBL] [Abstract][Full Text] [Related]
15. Cell-Laden Hydrogel as a Clinical-Relevant 3D Model for Analyzing Neuroblastoma Growth, Immunophenotype, and Susceptibility to Therapies.
Marrella A; Dondero A; Aiello M; Casu B; Olive D; Regis S; Bottino C; Pende D; Meazza R; Caluori G; Castriconi R; Scaglione S
Front Immunol; 2019; 10():1876. PubMed ID: 31447858
[TBL] [Abstract][Full Text] [Related]
16. Recruitment, Infiltration, and Cytotoxicity of HLA-Independent Killer Lymphocytes in Three-Dimensional Melanoma Models.
Iaia I; Gammaitoni L; Cattaneo G; Giraudo L; Donini C; Fiorino E; Primo L; Carnevale-Schianca F; Aglietta M; Puliafito A; Sangiolo D
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34065007
[TBL] [Abstract][Full Text] [Related]
17. In vitro humanized 3D microfluidic chip for testing personalized immunotherapeutics for head and neck cancer patients.
Al-Samadi A; Poor B; Tuomainen K; Liu V; Hyytiäinen A; Suleymanova I; Mesimaki K; Wilkman T; Mäkitie A; Saavalainen P; Salo T
Exp Cell Res; 2019 Oct; 383(2):111508. PubMed ID: 31356815
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast activation protein regulates natural killer cell migration, extravasation and tumor infiltration.
Weiner L; Fitzgerald A; Maynard R; Marcisak E; Nasir A; Glasgow E; Jablonski S; Van Der Veken P; Pearson G; Eisman S; Mace E; Fertig E
Res Sq; 2023 Dec; ():. PubMed ID: 38196606
[TBL] [Abstract][Full Text] [Related]
19. High-Throughput 3D
Song J; Choi H; Koh SK; Park D; Yu J; Kang H; Kim Y; Cho D; Jeon NL
Front Immunol; 2021; 12():733317. PubMed ID: 34630415
[TBL] [Abstract][Full Text] [Related]
20. The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their
Heinze A; Grebe B; Bremm M; Huenecke S; Munir TA; Graafen L; Frueh JT; Merker M; Rettinger E; Soerensen J; Klingebiel T; Bader P; Ullrich E; Cappel C
Front Immunol; 2019; 10():2816. PubMed ID: 31849984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
